Une récente étude a démontré que la transplantation fécale serait particulièrement intéressante chez les personnes…
MaaT PharmaSeptember 5, 2018
MaaT Pharma receives world-wide exclusive license to technology co-developed with hematology and gastroenterology departments of…
MaaT PharmaJune 21, 2018
A first glimpse of the evolution of a complex ecosystem during in vitro fermentation can…
MaaT PharmaJune 20, 2018
MaaT Pharma, a clinical-stage biopharmaceutical company, received authorization from competent authorities to launch its phase…
MaaT PharmaMarch 5, 2018
The French Microbiome company completed its first clinical study proving that Autologous Fecal Microbiota Transfer…
MaaT PharmaNovember 30, 2017